Premier Anti-Aging Co.,Ltd.

4934 TSE Chemicals Chemicals
TSE Growth
¥609.00
+2.18%
Delayed · cached 15 min

Fair value analysis

4934
Premier Anti-Aging Co.,Ltd.
ChemicalsChemicals
¥609.00
Close used for this calculation
¥974.35Fair value
Financial DNA Score
Profitability · Returns · Balance Sheet · Efficiency · Growth
63/100
Profitability14/25
Returns13/25
Balance Sheet18/25
Efficiency18/25
Growth20/25
Good
Quality radar
63Prof.14/25Ret.13/25Eff.18/25B.Sht18/25Growth20/25

Consensus fair value

¥974.35
Below FV
▲ +60.0% against the close used
Model range ¥480.68 – ¥3,104.34
The lowest and highest of the models that produced a value. This is the spread of the methods, not a price target.

Price target range & 52-week position

Bear¥480.68Fair value¥974.35Bull¥3,104.34
FairClose
52-week traded range
52W low ¥580.0052W high ¥897.00

The 52-week range is measured from the stored price history, not estimated.

Valuation summary

Trading below the consensus fair value

Premier Anti-Aging Co.,Ltd. closed at ¥609.00, 37.5% below the consensus fair value of ¥974.35 drawn from 8 valuation models.

Financial DNA score 63/100 — Good. P/E of 11.3x against the 20x sector multiple the P/E model uses.

Quantitative summary only — not investment advice.

All valuation models

DCF Valuation
¥3,104.34
+409.7%
Σ[CF×(1+g)^n/(1.10)^n] + TV/(1.10)^10
g=8%, r=10%, tg=3%, n=10yr
Graham Number
¥962.62
+58.1%
√(22.5 × EPS × BVPS)
EPS=54.1, BVPS=761.25
P/E Fair Value
¥1,082.00
+77.7%
EPS × 20x (sector P/E)
EPS=54.1, Sector P/E=20x
Peter Lynch (PEG)
¥1,623.00
+166.5%
EPS × Growth% (PEG = 1 is fair)
EPS=54.1, g=30%
EV/EBITDA
¥900.63
+47.9%
(EBITDA × 10x − Net Debt) ÷ Shares
EBITDA=874M
Book Value (P/B)
¥480.68
-21.1%
BVPS × (ROE−g)÷(r−g) [Justified P/B — RIM-based]
BVPS=761.25, ROE=7.4%, g=3%, r=10%
Reverse DCF
¥609.00
+0.0%
Solve for g: Price = Σ[EPS×(1+g)^n/(1.10)^n] + TV
Implied: -0.7% | Historical: -35.9%
Margin of Safety
¥1,287.24
+111.4%
Avg(DCF, Graham, P/E) × 75% (25% safety buffer)
Avg fair value=1716.32, MoS=25%

Computed on September 12, 2026 from the most recent annual report on file and that day's closing price. Where a company has seen its earnings move sharply since its last annual report, this figure will lag the market.

Educational data only. Not a recommendation to buy, sell or hold any security.

Educational data only. Not a recommendation to buy, sell or hold any security.